Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

New understanding and treatments for hair loss are improving, but more research is needed.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.